WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kantor, L.
Right arrow Articles by Gnegy, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kantor, L.
Right arrow Articles by Gnegy, M. E.

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 15, 1999, 19(10):3801-3808

Enhanced Amphetamine- and K+-Mediated Dopamine Release in Rat Striatum after Repeated Amphetamine: Differential Requirements for Ca2+- and Calmodulin-Dependent Phosphorylation and Synaptic Vesicles

Lana Kantor, G. H. Keikilani Hewlett, and Margaret E. Gnegy

Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0634

After cessation of repeated, intermittent amphetamine, we detected an emergent Ca2+-dependent component of amphetamine-induced dopamine release and an increase in calmodulin and Ca2+- and calmodulin-dependent protein kinase activity in rat striatum. This study examined the involvement of calmodulin-dependent protein kinase II (CaM kinase II) and synaptic vesicles in the enhanced Ca2+-dependent dopamine release in response to amphetamine or K+ in rat striatum. Rats were pretreated for 5 d with 2.5 mg/kg amphetamine or saline and withdrawn from drug for 10 d. The selective CaM kinase II inhibitor KN-93 (1 µM), but not the inactive analog KN-92, attenuated the Ca2+-dependent amphetamine-mediated dopamine release from amphetamine-pretreated rats but had no effect in saline-pretreated controls. [3H]Dopamine uptake was unaltered by repeated amphetamine or KN-93 and was Ca2+ independent. Striatal dopamine release stimulated by 50 mM KCl was enhanced twofold after repeated amphetamine compared with that in saline controls but was unaffected by KN-93. To examine the requirement for dopaminergic vesicles in the Ca2+-dependent dopamine release, we administered reserpine to saline- and amphetamine-pretreated rats 1 d before killing. Reserpine pretreatment did not affect amphetamine-mediated dopamine release from either pretreatment group but completely ablated K+-mediated dopamine release. Reserpine did not disrupt the ability of 1 µM KN-93 to block the Ca2+-dependent amphetamine-mediated dopamine release from amphetamine-pretreated rats. The results indicate that the enhanced dopamine release elicited by amphetamine from chronically treated rats is dependent on Ca2+- and calmodulin-dependent phosphorylation and is independent of vesicular dopamine storage. On the contrary, the enhanced depolarization-mediated vesicular dopamine release is independent of Ca2+- and calmodulin-dependent phosphorylation.

Key words: repeated amphetamine; dopamine transport; reserpine; CaM kinase II; depolarization; phosphorylation


Copyright © 1999 Society for Neuroscience  0270-6474/99/19103801-08$05.00/0


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. Wei, J. M. Williams, C. Dipace, U. Sung, J. A. Javitch, A. Galli, and C. Saunders
Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism
Mol. Pharmacol., March 1, 2007; 71(3): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
R. D. Blakely, L. J. DeFelice, and A. Galli
Biogenic Amine Neurotransmitter Transporters: Just When You Thought You Knew Them
Physiology, August 1, 2005; 20(4): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Kantor, M. Zhang, B. Guptaroy, Y. H. Park, and M. E. Gnegy
Repeated Amphetamine Couples Norepinephrine Transporter and Calcium Channel Activities in PC12 Cells
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1044 - 1051.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. Roman, S. N. Saldana, D. E. Nichols, F. I. Carroll, and E. L. Barker
Distinct Molecular Recognition of Psychostimulants by Human and Drosophila Serotonin Transporters
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 679 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Vezina, D. S. Lorrain, G. M. Arnold, J. D. Austin, and N. Suto
Sensitization of Midbrain Dopamine Neuron Reactivity Promotes the Pursuit of Amphetamine
J. Neurosci., June 1, 2002; 22(11): 4654 - 4662.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. M. Canals, N. Checa, S. Marco, P. Akerud, A. Michels, E. Perez-Navarro, E. Tolosa, E. Arenas, and J. Alberch
Expression of Brain-Derived Neurotrophic Factor in Cortical Neurons Is Regulated by Striatal Target Area
J. Neurosci., January 1, 2001; 21(1): 117 - 124.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-